rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Vivian H. Liu

Director

Company insider

Files Form 4 as: Director, Aytu BioPharma; Director, Innovus Pharmaceuticals; COO, Cesca Therapeutics; Executive Vice President, Apricus Biosciences.

Every Form 4 they filed

In numbers

Trades disclosed
58
Buys
0
Sells
0
Bought
$0
Sold
$0
Companies
4
Companies where not an officer
2
First trade
29 May 2005
Last trade
28 Jul 2026
Last filed
30 Jul 2026

Companies traded

Where they are an officer
Cesca TherapeuticsDirector, Officer · last 29 Dec 20170 buys · 0 sells
Apricus BiosciencesDirector, Officer · last 31 Dec 20100 buys · 0 sells
Everywhere else they filed: board seats, 10% stakes, other companies
AYTU Aytu BioPharmaDirector · Biotechnology · last 28 Jul 20260 buys · 0 sells
Innovus PharmaceuticalsDirector · last 2 Jan 20200 buys · 0 sells

Activity over time

Not enough dated trades to draw.

Every trade

TradedCompanyWhatAmount
28 Jul 2026filed 30 Jul 2026AYTU Aytu BioPharmaBiotechnologySEC FORM 4 Code A—10,000 at $0.00filing
28 Jul 2026filed 30 Jul 2026AYTU Aytu BioPharmaBiotechnologySEC FORM 4 Code A—10,000 at $0.00filing
3 Oct 2025filed 7 Oct 2025AYTU Aytu BioPharmaBiotechnologySEC FORM 4 Code A—10,000 at $0.00filing
6 Nov 2024filed 8 Nov 2024AYTU Aytu BioPharmaBiotechnologySEC FORM 4 Code A—1,500 at $0.00filing
11 Aug 2023filed 8 Nov 2024AYTU Aytu BioPharmaBiotechnologySEC FORM 4 Code A—1,500 at $0.00filing
11 Aug 2023filed 15 Aug 2023AYTU Aytu BioPharmaBiotechnologySEC FORM 4 Code A—1,500 at $0.00filing
8 Feb 2023filed 10 Feb 2023AYTU Aytu BioPharmaBiotechnologySEC FORM 4 Code A—6,500 at $0.00filing
1 Jul 2022filed 1 Jul 2022AYTU Aytu BioPharmaBiotechnologySEC FORM 4 Code A—6,500 at $0.00filing
2 Jan 2020filed 7 Jan 2020Innovus Pharmaceuticalsoption or derivativeSEC FORM 4 Code A$9,00010,112 at $0.89filing
1 Oct 2019filed 2 Oct 2019Innovus Pharmaceuticalsoption or derivativeSEC FORM 4 Code A$9,0014,286 at $2.10filing
1 Jul 2019filed 3 Jul 2019Innovus Pharmaceuticalsoption or derivativeSEC FORM 4 Code A$6,0013,948 at $1.52filing
1 Apr 2019filed 2 Apr 2019Innovus Pharmaceuticalsoption or derivativeSEC FORM 4 Code A$6,0011,095 at $5.48filing
2 Jan 2019filed 4 Jan 2019Innovus Pharmaceuticalsoption or derivativeSEC FORM 4 Code A$6,26989,552 at $0.07filing
1 Oct 2018filed 2 Oct 2018Innovus Pharmaceuticalsoption or derivativeSEC FORM 4 Code A$6,00050,000 at $0.12filing
1 Jul 2018filed 19 Jul 2018Innovus Pharmaceuticalsoption or derivativeSEC FORM 4 Code A$6,00054,545 at $0.11filing
1 Apr 2018filed 3 Apr 2018Innovus Pharmaceuticalsoption or derivativeSEC FORM 4 Code A$5,88749,059 at $0.12filing
23 Feb 2018filed 27 Feb 2018Innovus Pharmaceuticalsoption or derivativeSEC FORM 4 Code A$2,87435,928 at $0.08filing
23 Feb 2018filed 27 Feb 2018Innovus Pharmaceuticalsoption or derivativeSEC FORM 4 Code A$90K500,000 at $0.18filing
29 Dec 2017filed 3 Jan 2018Cesca Therapeuticsoption or derivativeSEC FORM 4 Code A—250,000 at $0.00filing
1 Oct 2017filed 2 Oct 2017Innovus Pharmaceuticalsoption or derivativeSEC FORM 4 Code A$2,96732,967 at $0.09filing

News

No headline names them, or the companies they trade most, lately.

Sectors

No trade we could place in a sector.

Related people

Nobody else traded the same names lately.